Skip to Main Content
1
Yale Interventional Endoscopy Program
Smilow Cancer Hospital at Yale New Haven
35 Park Street
New Haven, CT 06511
1 of 3
  • Yale Interventional Endoscopy Program
    Smilow Cancer Hospital at Yale New Haven
    35 Park Street
    New Haven, CT 06511
  • Yale Digestive Disorders
    Yale New Haven Hospital
    20 York Street
    New Haven, CT 06510
  • Smilow Cancer Genetics and Prevention
    Orchard Medical Center
    330 Orchard Street, Fl 1st Ste 107
    New Haven, CT 06511

James Farrell, MBChB

Genetics, Gastroenterology, Gastrointestinal Oncology, Hepatology
Telehealth is available
Learn more about telehealth
Patient type treated
Adult
Accepting new patients
Yes
Referral required
From patients or physicians

Biography

James Farrell, MBChB, is an internationally recognized expert in pancreatic diseases. He maintains a busy clinical practice focused on all aspects of interventional endoscopy, gastrointestinal cancer and pancreatic diseases including endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS) evaluation of pancreatic malignancy, pancreatic cysts, pancreatitis and individuals at risk for pancreatic malignancy.

 “My clinical commitment is to improve outcomes for patients with pancreatic disease, either by early detection or by optimizing treatment,” he says. “I tell patients and their families there are many treatment options out there and that this is about them—and us helping them manage their disease properly.”

 In addition to his clinical work and research, Dr. Farrell is director of the Yale Medicine Pancreatic Diseases Program, which brings together a variety of pancreatic specialists including gastroenterologists, surgeons, oncologists and nurses who focus on pancreatic disease. “The greatest development that’s happened in the field of pancreatic disease is our understanding of the basic mechanisms underlying these diseases that has allowed us to improve early detection as well as treatment responses,” Dr. Farrell says. “That really wasn’t there 10 years ago.”

 Dr. Farrell has addressed pancreatic disease on a national and international level as a member of such organizations as the NIH/NCI Pancreas Cancer Task Force. As a researcher, he is known for his development of personalized therapy approaches and early detection biomarkers for pancreatic cancer. He is an associate professor of medicine (digestive diseases) at Yale School of Medicine.

Titles

  • Professor of Medicine
  • Director, Yale Center for Pancreatic Diseases

Education & Training

  • Clinical Pharmacology Fellow
    UCLA School of Medicine (2007)
  • Advanced Interventional Endoscopy Fellowship
    Massachusetts General Hospital & Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (2001)
  • Clinical and Research Fellow in Gastroenterology
    Massachusetts General Hospital and Harvard Medical School, Boston, MA (2000)
  • Visiting Clinical Fellow
    The Academic Medical Center, Amsterdam, The Netherlands (1997)
  • Internal Medicine Residency
    The Johns Hopkins Hospital, Baltimore, MD (1997)
  • Visiting Clinical Fellow
    King’s College Hospital, London, England. (1995)
  • Resident in Gastroenterology and Oncology
    St James’ University Hospital, Trinity College Dublin, Ireland (1994)
  • MBChB
    University College (1992)
  • Internal Medicine Residency
    St Vincent’s University Hospital, University College Dublin, Ireland (1992)

Additional Information

Biography

James Farrell, MBChB, is an internationally recognized expert in pancreatic diseases. He maintains a busy clinical practice focused on all aspects of interventional endoscopy, gastrointestinal cancer and pancreatic diseases including endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS) evaluation of pancreatic malignancy, pancreatic cysts, pancreatitis and individuals at risk for pancreatic malignancy.

 “My clinical commitment is to improve outcomes for patients with pancreatic disease, either by early detection or by optimizing treatment,” he says. “I tell patients and their families there are many treatment options out there and that this is about them—and us helping them manage their disease properly.”

 In addition to his clinical work and research, Dr. Farrell is director of the Yale Medicine Pancreatic Diseases Program, which brings together a variety of pancreatic specialists including gastroenterologists, surgeons, oncologists and nurses who focus on pancreatic disease. “The greatest development that’s happened in the field of pancreatic disease is our understanding of the basic mechanisms underlying these diseases that has allowed us to improve early detection as well as treatment responses,” Dr. Farrell says. “That really wasn’t there 10 years ago.”

 Dr. Farrell has addressed pancreatic disease on a national and international level as a member of such organizations as the NIH/NCI Pancreas Cancer Task Force. As a researcher, he is known for his development of personalized therapy approaches and early detection biomarkers for pancreatic cancer. He is an associate professor of medicine (digestive diseases) at Yale School of Medicine.

Titles

  • Professor of Medicine
  • Director, Yale Center for Pancreatic Diseases

Education & Training

  • Clinical Pharmacology Fellow
    UCLA School of Medicine (2007)
  • Advanced Interventional Endoscopy Fellowship
    Massachusetts General Hospital & Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (2001)
  • Clinical and Research Fellow in Gastroenterology
    Massachusetts General Hospital and Harvard Medical School, Boston, MA (2000)
  • Visiting Clinical Fellow
    The Academic Medical Center, Amsterdam, The Netherlands (1997)
  • Internal Medicine Residency
    The Johns Hopkins Hospital, Baltimore, MD (1997)
  • Visiting Clinical Fellow
    King’s College Hospital, London, England. (1995)
  • Resident in Gastroenterology and Oncology
    St James’ University Hospital, Trinity College Dublin, Ireland (1994)
  • MBChB
    University College (1992)
  • Internal Medicine Residency
    St Vincent’s University Hospital, University College Dublin, Ireland (1992)

Additional Information

1
Yale Interventional Endoscopy Program
Smilow Cancer Hospital at Yale New Haven
35 Park Street
New Haven, CT 06511
1 of 3
  • Yale Interventional Endoscopy Program
    Smilow Cancer Hospital at Yale New Haven
    35 Park Street
    New Haven, CT 06511
  • Yale Digestive Disorders
    Yale New Haven Hospital
    20 York Street
    New Haven, CT 06510
  • Smilow Cancer Genetics and Prevention
    Orchard Medical Center
    330 Orchard Street, Fl 1st Ste 107
    New Haven, CT 06511